First FacebookLive

Mental Health Cop

I mentioned a short-time ago that I’d been asked to do some kind of CPD thing via social media where I could explain some stuff and people could ask questions.

I’m planning to start doing this and will be having a bit of a test-drive of the idea at 2pm on Thursday 14th March. I’m genuinely not bothered whether only a few people tune in (hence limited notice of it happening!), as the idea is just to give this a bash and for me to get use to doing it with the IT, etc.. Just seeing if it’s manageable.

Once I’ve got my head around it and if feedback suggests it’s worthwhile, we’ll give it a ‘proper’ go with more notice and a bit more pushing on social media for the fact that it’s happening.

So, Thursday 14th March at 2pm, if you’re free for 20minutes and especially…

View original post 529 more words


Dr Veronikis Gives Answers

Australian Pelvic Mesh Support Group

Dionysios K. Veronikis, MD, FACOG, FACS

Mesh removal is by far the most complicated and technically demanding procedure(s) a gynecologic surgeon can perform secondary to the scarring/adherence of the mesh on the delicate pelvic organs, the distorted anatomy, previously operated vaginal tissues and the mesh arms that penetrated the pelvic floor muscles.

Therefore, it is imperative that you do your own research and pursue mesh removal surgical treatment with a master vaginal surgeon, with a proven track record of successful and safe mesh removals, who is tenured in the treatment of vaginal prolapse and incontinence; and is able to remove the mesh without tissue destruction utilizing a tissue sparing removal technique by obtaining the needed surgical exposure.

Above all, it is the surgical skill set, experience and judgement of the surgeon that will make the difference for the outcomes of each particular patient and the quality of life.

When did…

View original post 2,458 more words

Soft Power [and telling stories]

Hole Ousia

This Feature Article made the cover of the BMJ:

One of the contributors described an approach to influencing healthcare policy as follows:

Telling stories is a well established approach taken by the commercial sector.

[These are the publicly available declarations of interest for this contributor:]

It seems that I am not alone in feeling most uncomfortable that another aspect of “soft power” is that it happens “behind closed doors”, as recognised in the article:

This single reference used in the article expands further on the approach of “soft power”:

“Soft power” is still power. Telling stories is not always the same as telling the truth. The shaping of policy “behind closed doors” excludes wider scrutiny. The power stays with the “narrative controllers”.

View original post

“He delivered piercing insights”

Hole Ousia

The Royal College of Psychiatristsdescribes“7 highlights” from its “sold-out”, and no doubt lucrative, International Congress 2018 which this year was held in Birmingham.

The Royal College of Psychiatrists gives this “keynote” as one of the highlights:

Professor Hamish-McAllister’s declarations of interest can be accessed from the British Association for Psychopharmacology. His declaration of 27th March 2017 confirms that in the previous three years, he had “accepted paid speaking engagements in industry supported symposia”from:

  1. AstraZeneca,
  2. Bristol Myers-Squibb,
  3. Eli Lilly,
  4. GlaxoSmithKline,
  5. Janssen-Cilag,
  6. LivaNova,
  7. Lundbeck,
  8. Merck Sharp & Dohme,
  9. Otsuka,
  10. Pfizer,
  11. Pulse,
  12. Roche,
  13. Servier,
  14. SPIMACO,
  15. Sunovian,
  16. Wyeth

It would be interesting to know how many of the  2,700 delegates from 54 countries, “more countries were represented than in the World Cup”  had  “piercing insight” into Professor Hamish McAllister-Williams extensive financial competing interests?

In June 2017, Professor Hamish-McAllister came to the small District General hospital that I work…

View original post 91 more words

“Objectivity” does not come in a title

Hole Ousia

On the 17 July 2018 Professor Roy Perlis shared the publication of this paper in which he was lead author:

Professor Perlis who is Director, Center for Experimental Drugs and Diagnostics, Massachusetts General Hospital did so with this introductory statement:

“Papers suggesting that antidepressants are associated with adverse birth outcomes get published in JAMA and hyped on NPR and BBC. Think this one, suggesting the same for psychotherapy, will get noticed? Confounding by indication is the point, of course.”

Two senior Scottish Psychiatrists shared this. One was Professor Keith Mathews and the other was Dr David Christmas, both of whom work for NHS Tayside.

In a post that I wrote in April 2018 I considered another recent paper by Professor Perlis, “Anxiety about Antidepressants” , where he considered “the cognitive and affective biases that may prevent effective treatment“. In this paper Professor Perlis referred to the recent publication…

View original post 159 more words